Monodisperse heterobifunctional PEGs of higher molecular weight for advanced pharmaceutical applications

Polypure monodisperse PEG derivative

Erik Agner, CEO Polypure AS The COVID-19 pandemic created a demand for a fast response to provide vaccines to a concerned world population. In this post, we will describe how Polypure developed monodisperse, heterobifunctional PEGs of higher molecular weights for advanced pharmaceutical applications based on the COVID-19 vaccine R&D project. The technology of mRNA incorporated … Read more

How can monodisperse PEG enhance drug development?

Polypure monodisperse PEG enhance drug development

In our recent article published on the prestigious Chemistry World website, we explore how monodisperse PEG from Polypure, with a defined and uniform molecular weight, enables a higher level of precision in drug development and bioconjugation. By eliminating molecular heterogeneity, monodisperse PEG supports more reliable characterisation, improved process control, and more consistent outcomes across research … Read more